Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.

NARecruitingINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

June 8, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

June 30, 2029

Conditions
Patent Foramen OvaleCryptogenic Stroke
Interventions
DEVICE

Cera™ patent foramen ovale occluders

Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with the Cera™ patent foramen ovale occluders according to the INSTRUCTIONS for Use (IFU).

DEVICE

Another patent foramen ovale occluders

Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with the Another patent foramen ovale occluders according to the INSTRUCTIONS for Use (IFU).

Trial Locations (14)

100034

NOT_YET_RECRUITING

Peking University First Hospital, Beijing

100037

NOT_YET_RECRUITING

Fuwai Hospital ,CAMS&PUMC, Beijing

110015

NOT_YET_RECRUITING

General Hospital of Northern Theater Command, Shenyang

130021

NOT_YET_RECRUITING

The First Hospital Of JiLin Universitv, Changchun

250012

NOT_YET_RECRUITING

Qilu Hospitalof Shandong University, Jinan

250014

NOT_YET_RECRUITING

The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan

310014

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

315010

NOT_YET_RECRUITING

The First Affiliated Hospital of Ningbo University, Ningbo

325000

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

410000

RECRUITING

The Second XiangYa Hospital of Central South University, Changsha

RECRUITING

The Third XiangYa Hospital of Central South University, Changsha

510080

RECRUITING

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

514031

RECRUITING

Meizhou people'Hospital, Meizhou

650000

RECRUITING

Fuwai Yunnan Cardiovascular Hospital, Kunming

All Listed Sponsors
lead

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY